Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special Reports
Special Reports
The top 10 drugs losing US exclusivity in 2024
The unrelenting churning of time means many things to many people. For pharma execs, it’s a constant reminder of the need for new launches to supplant old meds.
Eric Sagonowsky
,
Fraiser Kansteiner
,
Zoey Becker
,
Angus Liu
,
Kevin Dunleavy
Mar 11, 2024 3:00am
The top 10 biopharma M&A deals of 2023
Feb 5, 2024 3:00am
Top 10 most anticipated drug launches of 2024
Jan 29, 2024 6:00am
2023 approvals: Biopharma delivered 60+ new drugs, biologics
Jan 2, 2024 3:00am
2023's Fiercest Women in Life Sciences
Nov 27, 2023 3:00am
Fierce 50: Innovation honorees
Oct 2, 2023 4:00am